Cargando…

Assessing and improving value in cancer care : workshop summary /

"Unlike many other areas in health care, the practice of oncology presents unique challenges that make assessing and improving value especially complex. First, patients and professionals feel a well-justified sense of urgency to treat for cure, and if cure is not possible, to extend life and re...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: National Cancer Policy Forum (U.S.)
Otros Autores: Schickedanz, Adam
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Washington, D.C. : National Academies Press, ©2009.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000Ma 4500
001 EBOOKCENTRAL_ocn649901506
003 OCoLC
005 20240329122006.0
006 m o d
007 cr cn|||||||||
008 091202s2009 dcua ob 100 0 eng d
010 |a  2010277743 
040 |a E7B  |b eng  |e pn  |c E7B  |d OCLCQ  |d N$T  |d IDEBK  |d COF  |d CDS  |d CU3  |d OCLCQ  |d FVL  |d OCLCQ  |d YDXCP  |d OCLCF  |d OCLCQ  |d NLGGC  |d MMU  |d N15  |d OCLCQ  |d EBLCP  |d OCLCQ  |d AZK  |d TOA  |d AGLDB  |d UAB  |d COCUF  |d OCLCO  |d MOR  |d OCLCO  |d PIFAG  |d OCLCQ  |d ZCU  |d OCLCO  |d OCLCQ  |d MERUC  |d OCLCO  |d OCLCQ  |d MERER  |d NJR  |d OCLCO  |d U3W  |d BUF  |d OCLCO  |d OCLCQ  |d OCLCO  |d CUY  |d VT2  |d OCLCO  |d OCLCQ  |d OCL  |d OCLCO  |d STF  |d VNS  |d WRM  |d OCLCQ  |d VTS  |d OCLCQ  |d ICG  |d OCLCO  |d NRAMU  |d OCLCO  |d AU@  |d OCLCO  |d WYU  |d OCLCO  |d OCLCQ  |d LVT  |d S9I  |d OCLCO  |d OCLCQ  |d DKC  |d OCLCO  |d OCLCQ  |d M8D  |d OCLCO  |d OCL  |d OCLCO  |d OCLCQ  |d OCLCO  |d UKAHL  |d OCLCQ  |d OCLCA  |d SFB  |d OCLCA  |d UKCRE  |d AJS  |d SDF  |d TUHNV  |d OCLCO  |d OCLCQ  |d OCL  |d OCLCO  |d OCLCL 
019 |a 466825698  |a 549307653  |a 722735347  |a 728058788  |a 923281077  |a 961531503  |a 962598662  |a 988430214  |a 991912278  |a 1021261500  |a 1028775956  |a 1037908346  |a 1038680331  |a 1045523158  |a 1055338010  |a 1064758687  |a 1081194634  |a 1119518714  |a 1125509696  |a 1153516577  |a 1156391451  |a 1200873175  |a 1204384425  |a 1204394778  |a 1228556370  |a 1249247370 
020 |a 9780309138154  |q (electronic bk.) 
020 |a 0309138159  |q (electronic bk.) 
020 |z 0309138140 
020 |z 9780309138147 
020 |a 1282437224 
020 |a 9781282437227 
020 |a 9786612437229 
020 |a 6612437227 
029 1 |a AU@  |b 000051461318 
029 1 |a DEBBG  |b BV043112505 
029 1 |a DEBBG  |b BV044108996 
029 1 |a DEBSZ  |b 421925019 
029 1 |a NZ1  |b 13448631 
029 1 |a AU@  |b 000075795792 
035 |a (OCoLC)649901506  |z (OCoLC)466825698  |z (OCoLC)549307653  |z (OCoLC)722735347  |z (OCoLC)728058788  |z (OCoLC)923281077  |z (OCoLC)961531503  |z (OCoLC)962598662  |z (OCoLC)988430214  |z (OCoLC)991912278  |z (OCoLC)1021261500  |z (OCoLC)1028775956  |z (OCoLC)1037908346  |z (OCoLC)1038680331  |z (OCoLC)1045523158  |z (OCoLC)1055338010  |z (OCoLC)1064758687  |z (OCoLC)1081194634  |z (OCoLC)1119518714  |z (OCoLC)1125509696  |z (OCoLC)1153516577  |z (OCoLC)1156391451  |z (OCoLC)1200873175  |z (OCoLC)1204384425  |z (OCoLC)1204394778  |z (OCoLC)1228556370  |z (OCoLC)1249247370 
043 |a n-us--- 
050 4 |a RC262  |b .A79 2009eb 
060 4 |a QZ 266 A846 2009 
072 7 |a MED  |x 062000  |2 bisacsh 
072 7 |a HEA  |x 039030  |2 bisacsh 
082 0 4 |a 616.994  |2 22 
049 |a UAMI 
245 0 0 |a Assessing and improving value in cancer care :  |b workshop summary /  |c Adam Schickedanz, rapporteur ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies. 
260 |a Washington, D.C. :  |b National Academies Press,  |c ©2009. 
300 |a 1 online resource (xvi, 148 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a data file  |2 rda 
504 |a Includes bibliographical references. 
505 0 |a Introduction -- Opening remarks: what is value in cancer care and why is it important? -- Part I. Challenges to value in cancer care. Clinician-patient communication and its influence and value -- Generating evidence about effectiveness and value -- Value and the oncology market -- Value in oncology practice; oncologist and health insurer perspectives -- pt. II. Ethical issues and value in oncology. Solutions for value in cancer care -- Improving value in oncology practice: ways forward -- Toward a shared understanding of value -- Acronyms -- Glossary -- Appendix A. Workshop agenda -- Appendix B. Speaker and moderator biographies. 
520 |a "Unlike many other areas in health care, the practice of oncology presents unique challenges that make assessing and improving value especially complex. First, patients and professionals feel a well-justified sense of urgency to treat for cure, and if cure is not possible, to extend life and reduce the burden of disease. Second, treatments are often both life sparing and highly toxic. Third, distinctive payment structures for cancer medicines are intertwined with practice. Fourth, providers often face tremendous pressure to apply the newest technologies to patients who fail to respond to established treatments, even when the evidence supporting those technologies is incomplete or uncertain, and providers may be reluctant to stop toxic treatments and move to palliation, even at the end of life. Finally, the newest and most novel treatments in oncology are among the most costly in medicine. This volume summarizes the results of a workshop that addressed these issues from multiple perspectives, including those of patients and patient advocates, providers, insurers, health care researchers, federal agencies, and industry. Its broad goal was to describe value in oncology in a complete and nuanced way, to better inform decisions regarding developing, evaluating, prescribing, and paying for cancer therapeutics."--Publisher's description. 
588 0 |a Print version record. 
546 |a English. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Cancer  |x Patients  |x Medical care. 
650 0 |a Cancer  |x Treatment  |x Economic aspects. 
650 0 |a Cancer. 
650 0 |a Patients. 
650 0 |a Cost effectiveness. 
650 0 |a Medical economics. 
650 2 |a Patients 
650 1 2 |a Cost-Benefit Analysis 
650 2 2 |a Neoplasms  |x prevention & control 
650 2 2 |a Economics, Medical 
650 2 2 |a Neoplasms  |x therapy 
650 2 2 |a Neoplasms  |x economics 
650 2 2 |a Outcome Assessment, Health Care  |x economics 
651 2 |a United States 
650 2 |a Neoplasms 
650 6 |a Cancéreux  |x Soins médicaux. 
650 6 |a Cancer  |x Traitement  |x Aspect économique. 
650 6 |a Cancer. 
650 6 |a Patients. 
650 6 |a Coût-efficacité. 
650 6 |a Économie de la santé. 
650 7 |a patients.  |2 aat 
650 7 |a cost benefit analysis.  |2 aat 
650 7 |a MEDICAL  |x Oncology.  |2 bisacsh 
650 7 |a HEALTH & FITNESS  |x Diseases  |x Cancer.  |2 bisacsh 
650 7 |a Patients  |2 fast 
650 7 |a Medical economics  |2 fast 
650 7 |a Cost effectiveness  |2 fast 
650 7 |a Cancer  |2 fast 
650 7 |a Cancer  |x Patients  |x Medical care  |2 fast 
650 7 |a Cancer  |x Treatment  |x Economic aspects  |2 fast 
655 2 |a Congress 
655 7 |a proceedings (reports)  |2 aat 
655 7 |a Conference papers and proceedings  |2 fast 
655 7 |a Conference papers and proceedings.  |2 lcgft 
655 7 |a Actes de congrès.  |2 rvmgf 
700 1 |a Schickedanz, Adam. 
710 2 |a National Cancer Policy Forum (U.S.) 
758 |i has work:  |a Assessing and improving value in cancer care (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCFt3QbW6hMvGhGk8gdTF4y  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |t Assessing and improving value in cancer care.  |d Washington, D.C. : National Academies Press, ©2009  |z 9780309138147  |w (OCoLC)472200978 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3378554  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH36615245 
938 |a Askews and Holts Library Services  |b ASKH  |n AH36558483 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL3378554 
938 |a ebrary  |b EBRY  |n ebr10355552 
938 |a EBSCOhost  |b EBSC  |n 301428 
938 |a ProQuest MyiLibrary Digital eBook Collection  |b IDEB  |n 243722 
938 |a YBP Library Services  |b YANK  |n 3289045 
994 |a 92  |b IZTAP